Arisan Elif Damla, Arisan Serdar, Atis Gokhan, Palavan-Unsal Narcin, Ergenekon Erbil
1st Urology Clinics, Sişli Etfal Research and Training Hospital, Sisli-Istanbul, Turkey.
Urol Int. 2009;82(2):203-8. doi: 10.1159/000200801. Epub 2009 Mar 19.
We estimated the circulating levels of adipocytokines such as adiponectin and leptin in nonobese nondiabetic prostate cancer (PCa) patients and compared the results with controls and benign prostate hyperplasia (BPH) patients.
Fifty patients with PCa, 20 patients with BPH and 50 healthy volunteers were entered into the study. Their blood samples were investigated for adipocytokines with the ELISA method.
Adiponectin levels were determined as 8.9 and 5.5 microg/ml for the same patients. Leptin concentration was 14.78 ng/ml in organ-confined PCa patients, and 15.24 ng/ml in advanced PCa patients. In control patients, adiponectin and leptin levels were 18.4 and 12.98 ng/ml, respectively.
Serum adipocytokine levels of PCa patients were significantly different from those of controls and BPH patients who were not obese or diabetic. Therefore, further molecular investigation of these adipocytokines will help understand the mechanism.
我们评估了非肥胖非糖尿病前列腺癌(PCa)患者中脂联素和瘦素等脂肪细胞因子的循环水平,并将结果与对照组及良性前列腺增生(BPH)患者进行比较。
50例PCa患者、20例BPH患者和50名健康志愿者纳入本研究。采用酶联免疫吸附测定(ELISA)法检测他们血液样本中的脂肪细胞因子。
同一批患者的脂联素水平分别测定为8.9和5.5微克/毫升。局限于器官的PCa患者瘦素浓度为14.78纳克/毫升,晚期PCa患者为15.24纳克/毫升。对照组患者的脂联素和瘦素水平分别为18.4和12.98纳克/毫升。
PCa患者的血清脂肪细胞因子水平与非肥胖或非糖尿病的对照组及BPH患者有显著差异。因此,对这些脂肪细胞因子进行进一步的分子研究将有助于了解其机制。